Sonoma Pharmaceuticals (SNOA) vs Tenon Medical (TNON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Sonoma Pharmaceuticals is the larger company by market cap ($3.7 million vs $2.4 million), about 1.5 times the size. Sonoma Pharmaceuticals converts more of its revenue into profit, with a net margin of -16.3% versus -318.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SNOA | TNON |
|---|---|---|
| Share price | $0.722 | $0.8972 |
| Market cap | $3.65M | $2.41M |
| 1-day change | -10.83% | -8.97% |
| YTD return | — | -97.31% |
| 1-year return | — | -97.67% |
| EPS (TTM) | $-0.90 | $-30.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $19.53M | $3.94M |
| Revenue growth (YoY) | +36.68% | +20.35% |
| Net income (latest FY) | $-3.17M | $-12.56M |
| Gross margin | 37.97% | 59.79% |
| Operating margin | -12.60% | -324.34% |
| Net margin | -16.26% | -318.36% |
| 52-week high | $3.95 | $40.95 |
| 52-week low | $0.72 | $0.886 |
| Distance from 52-week high | -81.72% | -97.81% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +4846.50% |
| Average volume | 61.96K | 5.46M |
| Shares outstanding | 5.06M | 2.68M |
| Employees | 10 | 26 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sonoma Pharmaceuticals is more profitable, keeping -16.3 cents of every revenue dollar as net income versus -318.4 cents for Tenon Medical.
- Sonoma Pharmaceuticals grew revenue faster in its latest fiscal year (+36.68% vs +20.35%).
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
About Tenon Medical
TNON stock →Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.
Health Care · Medical/Dental Instruments · 26 employees
SNOA vs TNON FAQ
Which is bigger, Sonoma Pharmaceuticals or Tenon Medical?
Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $3.65M compared with $2.41M for Tenon Medical (TNON).
Are Sonoma Pharmaceuticals and Tenon Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.